Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Mercedes Santoro

Showing results (11-20 of 134) with videos related to

Pageof 14
Sort By:
Sexually Transmitted Infections|September 17, 2024
Managing low-level HIV viraemia in antiretroviral therapy: a systematic review and meta-analysisDrieda Zaçe, Lorenzo Vittorio Rindi, Mirko Compagno, et al.
AIDS Research and Human Retroviruses|November 26, 2015
Short Communication: Population-Based Surveillance of HIV-1 Drug Resistance in Cameroonian Adults Initiating Antiretroviral Therapy According to the World Health Organization GuidelinesJoseph Fokam, Désiré Takou, Maria Mercedes Santoro, et al.
The Journal of Antimicrobial Chemotherapy|March 12, 2020
Identification of gp120 polymorphisms in HIV-1 B subtype potentially associated with resistance to fostemsavirYagai Bouba, Giulia Berno, Lavinia Fabeni, et al.
AIDS Research and Human Retroviruses|September 16, 2008
Characterization of drug-resistance mutations in HIV type 1 isolates from drug-naive and ARV-treated patients in BulgariaMaria Mercedes Santoro, Massimo Ciccozzi, Claudia Alteri, et al.
The New Microbiologica|May 3, 2024
PRESTIGIO RING "a 59-year-old man with multidrug resistant HIV-1 infection failing a regimen including dolutegravir, rilpivirine, atazanavir/cobicistat: successful treatment tailoring based on genotypic and phenotypic resistance tests"Francesca Panza, Francesco Saladini, Niccolò Bartolini, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 13, 2010
Population dynamics of HIV-1 subtype B in a cohort of men-having-sex-with-men in Rome, ItalyGianguglielmo Zehender, Erika Ebranati, Alessia Lai, et al.
Journal of Global Antimicrobial Resistance|December 29, 2024
Next-generation sequencing and drug resistance mutations of HIV-1 subtypes in people living with HIV in Sicily, Italy, 2021-2023Luca Pipitò, Marcello Trizzino, Chiara Mascarella, et al.
The Journal of Infection|March 13, 2023
Inflammation burden score in multidrug-resistant HIV-1 infectionTommaso Clemente, Roberta Caccia, Laura Galli, et al.
International Journal of Antimicrobial Agents|March 4, 2023
Evaluation of HIV-DNA and residual viremia levels through week 96 in HIV-infected individuals who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor-based regimenRossana Scutari, Laura Galli, Claudia Alteri, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 2, 2020
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronavirusesAnna Artese, Valentina Svicher, Giosuè Costa, et al.
Pageof 14

Showing results (11-20 of 134) with videos related to

Sort By:
Pageof 14
Sexually Transmitted Infections|September 17, 2024
Managing low-level HIV viraemia in antiretroviral therapy: a systematic review and meta-analysisDrieda Zaçe, Lorenzo Vittorio Rindi, Mirko Compagno, et al.
AIDS Research and Human Retroviruses|November 26, 2015
Short Communication: Population-Based Surveillance of HIV-1 Drug Resistance in Cameroonian Adults Initiating Antiretroviral Therapy According to the World Health Organization GuidelinesJoseph Fokam, Désiré Takou, Maria Mercedes Santoro, et al.
The Journal of Antimicrobial Chemotherapy|March 12, 2020
Identification of gp120 polymorphisms in HIV-1 B subtype potentially associated with resistance to fostemsavirYagai Bouba, Giulia Berno, Lavinia Fabeni, et al.
AIDS Research and Human Retroviruses|September 16, 2008
Characterization of drug-resistance mutations in HIV type 1 isolates from drug-naive and ARV-treated patients in BulgariaMaria Mercedes Santoro, Massimo Ciccozzi, Claudia Alteri, et al.
The New Microbiologica|May 3, 2024
PRESTIGIO RING "a 59-year-old man with multidrug resistant HIV-1 infection failing a regimen including dolutegravir, rilpivirine, atazanavir/cobicistat: successful treatment tailoring based on genotypic and phenotypic resistance tests"Francesca Panza, Francesco Saladini, Niccolò Bartolini, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 13, 2010
Population dynamics of HIV-1 subtype B in a cohort of men-having-sex-with-men in Rome, ItalyGianguglielmo Zehender, Erika Ebranati, Alessia Lai, et al.
Journal of Global Antimicrobial Resistance|December 29, 2024
Next-generation sequencing and drug resistance mutations of HIV-1 subtypes in people living with HIV in Sicily, Italy, 2021-2023Luca Pipitò, Marcello Trizzino, Chiara Mascarella, et al.
The Journal of Infection|March 13, 2023
Inflammation burden score in multidrug-resistant HIV-1 infectionTommaso Clemente, Roberta Caccia, Laura Galli, et al.
International Journal of Antimicrobial Agents|March 4, 2023
Evaluation of HIV-DNA and residual viremia levels through week 96 in HIV-infected individuals who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor-based regimenRossana Scutari, Laura Galli, Claudia Alteri, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 2, 2020
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronavirusesAnna Artese, Valentina Svicher, Giosuè Costa, et al.
Pageof 14